SGEM#453: I Can’t Go For That – No, No Narcan for Out-of-Hospital Cardiac Arrests
Sep 21, 2024
auto_awesome
Dr. Chris Root, an emergency medicine physician with expertise in EMS from the University of New Mexico, dives into the controversial role of naloxone in out-of-hospital cardiac arrests. He discusses a recent study from California, highlighting the implications of naloxone on survival rates. The conversation navigates the complexities of administering the drug, the importance of patient outcomes, and critiques the reliance on statistical measures like NNT. Ethical considerations surrounding organ donation are also touched upon, adding depth to this critical topic.
Naloxone shows potential in improving survival rates during out-of-hospital cardiac arrests linked to opioid use, necessitating further research.
Variability in EMS protocols regarding naloxone use highlights the need for consistency and evidence in emergency resuscitation practices.
Deep dives
Understanding Naloxone's Role in Cardiac Arrest
Naloxone, a medication primarily used to reverse opioid overdoses, is increasingly recognized for its potential role in out-of-hospital cardiac arrest (OCA). This episode discusses a case where naloxone may aid patients experiencing cardiac arrest linked to opioid use, as opioids can induce respiratory depression leading to hypoxia and subsequent cardiac arrest. While traditional guidelines have recommended naloxone mainly for suspected overdoses, new perspectives are emerging regarding its utility in OCA, given the rising incidence of opioid-related incidents. Despite its promise, the effectiveness of naloxone in improving survival rates during cardiac arrest remains a subject of ongoing research and varying EMS practices, creating a need for further investigation into its application in emergency protocols.
Key Findings from Recent Research
A recent retrospective cohort study examined the impact of naloxone on survival rates in patients experiencing out-of-hospital cardiac arrest across three California counties. The study found that naloxone administration during resuscitation was associated with improved rates of return of spontaneous circulation (ROSC) and overall survival to hospital discharge, with figures reflecting a 6% absolute risk increase in survival. However, only 14% of the observed patients received naloxone, indicating a significant disparity in its administration compared to those who did not. These findings encourage emergency medical services to consider naloxone as part of their resuscitation protocols, especially in cases associated with opioid use, while continuing to emphasize the critical role of high-quality CPR and early defibrillation.
Challenges and Considerations in Implementation
While the potential benefits of naloxone in OCA situations are notable, the discussion highlights several challenges in its implementation. Variability in EMS protocols regarding naloxone use raises concerns about consistency and evidence supporting its integration into standard practices for cardiac arrests. Additionally, factors such as the timing and method of naloxone administration during resuscitation remain unclear, which complicates the overall interpretation of its impact. The podcast underscores the importance of robust prospective randomized control trials to better elucidate the nuances of naloxone's effectiveness in the realm of emergency medicine and improve patient outcomes.
Date: September 18, 2024 Reference: Dillon et al. Naloxone and Patient Outcomes in Out-of-Hospital Cardiac Arrests in California. JAMA Network Open. August 20, 2024 Guest Skeptic: Dr. Chris Root is an emergency medicine and emergency medicine service (EMS) physician at the University of New Mexico, Albuquerque. Before attending medical school, he was a New York […]